The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives-Reference-Cited by-同舟云学术

The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives

Published:2020 Issue:17 Volume:8 Page:4653-4664
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Foulkes Rachel¹²³⁴,Man Ernest⁵⁶⁷⁴,Thind Jasmine¹²³⁴,Yeung Suet¹²³⁴,Joy Abigail¹²³⁴,Hoskins Clare¹²³⁴⁵^ORCID

Affiliation:

1. School of Pharmacy and Bioengineering

2. Keele University

3. Keele

4. UK

5. Department of Pure and Applied Chemistry

6. University of Strathclyde

7. Glasgow

Abstract

Nanomedicine research has increased drastically over the past ten years, however, before clinical translation many regulatory factors must be considered.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2020/BM/D0BM00558D

Reference80 articles.

1. http://www.britishsocietynanomedicine.org/what-is-nanomedicine/

2. Nanotechnology for electronics & photonics

3. Trade-offs in ecosystem impacts from nanomaterial versus organic chemical ultraviolet filters in sunscreens

4. Current status and future prospects of nanotechnology in cosmetics

5. Energy storage: The future enabled by nanomaterials

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calendula in modern medicine: Advancements in wound healing and drug delivery applications;European Journal of Medicinal Chemistry Reports;2024-12

2. Integrated in silico analysis of transcriptomic alterations in nanoparticle toxicity across human and mouse models;Science of The Total Environment;2024-11

3. Nanoemulsions of essential oils against multi-resistant microorganisms: An integrative review;Microbial Pathogenesis;2024-10

4. Advances in polymer-centric nanomedicines for theranostic cancer treatment;Journal of Drug Delivery Science and Technology;2024-10

5. Alternative routes for parenteral nucleic acid delivery and related hurdles: highlights in RNA delivery;Expert Opinion on Drug Delivery;2024-09-13